Qubit Pharmaceuticals is a brand-new international company, spun off from CNAM, CNRS, University of Texas at Austin, Sorbonne University and Washington University, and based in Paris. Qubit Pharmaceuticals builds upon more than 20 years of R&D awarded by the most prestigious prizes.
Qubit Pharmaceuticals is supported by Quantonation, a leading investment fund in quantum technologies in its mission to revolutionize the way drugs are developed and provide safer and more efficient drugs faster.
Qubit Pharmaceuticals is laureate of the EIT health headstart program and incubated at Paris Biotech Santé.